Schrodinger Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
And I think we are live. Welcome, everybody. My name is Chris Shibutani. I am a member of the Goldman Sachs equity research team. I'm joined by my colleague, CJ Zopf, and the 2 of us are very pleased to have joining us today to present at our conference, the 42nd Annual Goldman Healthcare Conference, still virtual, hopefully, live next year, Schrödinger.
The company has done so much to really create an opportunity for investors to think more broadly about investing in the life sciences with so many tangencies relevant to therapeutics investors. So I think this will be a very interesting discussion, and we're going to take it from a bit of an educational approach and have a management team tell us a little bit about their story.
Here to join us, we have Ramy Farid, who's President and CEO; Karen Akinsanya, who is the Head of the Biomedical Sciences and the Discovery Group; and Joel Lebowitz, the Chief Financial Officer.
So Ramy and Karen, I think you're going to present us with a summary of a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
